IDAC Theranostics Overview

  • Year Founded
  • 2012

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 1

IDAC Theranostics General Information

Description

Developer of drug therapies designed for diseases for which there is only symptomatic treatment. The company collaborates with Japanese academics, pharmaceutical companies, as well as foreign entities, to research and develop cures for illnesses such as inflammatory diseases and cancer, enabling healthcare providers and pharmaceuticals to provide more meaningful results for patients with unmet needs.

Contact Information

Website
www.idac-thera.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 1-3 Machida Heights Ichibankan
  • 1-13-1 Haramachida, Machida City
  • Tokyo, 194-0013
  • Japan
+81
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Pharmaceuticals
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • 1-3 Machida Heights Ichibankan
  • 1-13-1 Haramachida, Machida City
  • Tokyo, 194-0013
  • Japan
+81

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

IDAC Theranostics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Secondary Transaction - Private 01-Mar-2023 Completed Generating Revenue
5. Later Stage VC 29-Sep-2017 Completed Generating Revenue
4. Early Stage VC 07-Nov-2014 Completed Startup
3. Early Stage VC 30-Aug-2013 Completed Startup
2. Early Stage VC 25-Mar-2013 $603K $603K Completed Startup
1. Seed Round 08-Jun-2012 Completed Startup
To view IDAC Theranostics’s complete valuation and funding history, request access »

IDAC Theranostics Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Class A Preferred
To view IDAC Theranostics’s complete cap table history, request access »

IDAC Theranostics Patents

  • 42

    Total Documents Applications and Grants

  • Total Patents Families

  • 27

    Granted

  • 1

    Pending

  • Expiring in next 12 mo

IDAC Theranostics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-WO2020013133-A1 Portable microwell plate for single cell analysis and cell lysate containing gelling agent Inactive 09-Jul-2018
EP-3530652-A1 Modified phenylphthalimide and pharmaceutical composition having same as active ingredient Inactive 21-Oct-2016
US-20190315775-A1 Modified phenylphthalimide and pharmaceutical composition having same as active ingredient Inactive 21-Oct-2016
JP-WO2018074563-A1 Phenylphthalimide modified product and pharmaceutical composition containing the same Inactive 21-Oct-2016
EP-3530652-A4 Modified phenylphthalimide and pharmaceutical composition having same as active ingredient Inactive 21-Oct-2016 C07F5/00
To view IDAC Theranostics’s complete patent history, request access »

IDAC Theranostics Executive Team (2)

Name Title Board Seat
Satoru Ito Chief Executive Officer, Chief Technology Officer, President & Board Member
Jun Kanma Chief Financial Officer & Board Member
To view IDAC Theranostics’s complete executive team members history, request access »

IDAC Theranostics Board Members (4)

Name Representing Role Since
Jun Kanma IDAC Theranostics Chief Financial Officer & Board Member
Satoru Ito IDAC Theranostics Chief Executive Officer, Chief Technology Officer, President & Board Member
Shinichi Kamachi Self Board Member
Tetsumasa Yamada Self Board Member
To view IDAC Theranostics’s complete board members history, request access »

IDAC Theranostics Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Keio Innovation Initiative Venture Capital Minority
To view IDAC Theranostics’s complete investors history, request access »

Ready to get started?

Request a free trial

IDAC Theranostics FAQs

  • When was IDAC Theranostics founded?

    IDAC Theranostics was founded in 2012.

  • Who is the CEO of IDAC Theranostics?

    Satoru Ito is the CEO of IDAC Theranostics.

  • Where is IDAC Theranostics headquartered?

    IDAC Theranostics is headquartered in Tokyo, Japan.

  • What industry is IDAC Theranostics in?

    IDAC Theranostics’s primary industry is Drug Discovery.

  • Is IDAC Theranostics a private or public company?

    IDAC Theranostics is a Private company.

  • What is IDAC Theranostics’s current revenue?

    The current revenue for IDAC Theranostics is .

  • How much funding has IDAC Theranostics raised over time?

    IDAC Theranostics has raised $10.8M.

  • Who are IDAC Theranostics’s investors?

    Keio Innovation Initiative has invested in IDAC Theranostics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »